Company: CPMV
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001683168-25-002584
Chunk: 287

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1B
Chunk 287
---
 determination of a single business segment is consistent with the consolidated
financial information regularly provided to the Company’s chief operating decision maker (“CODM”). The Company’s
CODM is its President and Chief Executive Officer, who reviews and evaluates consolidated net loss for purposes of making operating decisions.

15. Subsequent Events

We have evaluated subsequent events after the consolidated
balance sheet date and through the filing date of this Report, and based on our evaluation, management has determined that no other subsequent
events have occurred that would require recognition in the accompanying consolidated financial statements or disclosure in the notes thereto
other than as disclosed herein and in the accompanying notes.

 F-25